Skip to main content
NVDA-2.44%AAPL+3.15%GOOGL+0.44%MSFT-0.14%AMZN-0.22%TSM-1.32%SPCX+0.84%AVGO-0.58%META-1.20%TSLA-0.40%SKHY-4.06%MU-4.40%BRK-B-0.25%LLY-0.13%JPM-0.68%WMT-0.14%AMD-3.07%V-0.22%XOM+0.64%ASMLa-1.66%JNJ-0.16%INTC-4.61%MA-0.60%0700.HK-1.94%1398.HK+0.79%ORCL-3.99%ABBV+0.96%BAC-0.52%CSCO-1.09%CVX-0.39%COST-0.17%KO+0.61%LRCX-4.98%CAT-1.42%AP2d-1.55%0005.HK-0.78%AMAT-2.60%UNH-1.05%HSBA.L-1.30%DELL-3.48%PG+0.46%MS-1.08%GE-0.65%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.26%HD-1.88%0939.HK+1.66%GS-1.16%NZDJPY-2.62%AUDJPY-1.83%CHFJPY-1.60%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.25%USDJPY-1.23%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.97%USDNOK+0.91%USDSEK+0.88%AUDNZD+0.82%EURZAR+0.80%EURNOK+0.73%GBPZAR+0.72%EURSEK+0.71%AUDCAD-0.69%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.61%USDTHB+0.60%CHFNOK+0.57%GBPAUD+0.57%CHFSEK+0.55%AUDSGD-0.54%USDMXN+0.51%USDPLN+0.43%NZDSGD-0.42%CADCHF+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.27%EURPLN+0.26%SGDJPY+0.24%AUDCHF-0.23%NZDMXN-0.21%EURHKD-0.18%USDDKK+0.17%USDILS+0.16%USDTRY+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%AUDNOK+0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%EURCNH-0.05%EURCZK-0.05%USDCAD-0.05%USDCOP-0.04%EURGBP+0.04%GBPUSD-0.02%USDHKD+0.02%GBPSGD+0.02%EURUSD0.00%EURDKK0.00%XPTUSD-5.92%XAGUSD-5.06%GAGUSD-5.06%UKOIL+4.96%HG1-4.82%USOIL+4.74%XNGUSD+1.63%GAUUSD-1.55%XAUUSD-1.55%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.37%ETHUSD-0.03%USDTUSD-0.02%XRPUSD-2.84%SOLUSD-1.64%TRXUSDT+0.24%ZECUSDT-8.36%DOGEUSD-2.56%XMRUSDT+0.47%LINKUSD-1.12%XLMUSD-1.17%BCHUSDT-9.67%LTCUSD-1.50%UNIUSD-1.03%TONUSD+24.88%HBARUSDT-2.32%SUIUSD-3.99%TAOUSDT-5.17%AAVEUSD-2.21%DOTUSDT-1.56%ICPUSDT-0.72%ONDOUSDT-2.95%WLDUSDT-2.43%ATOMUSDT-2.11%ARBUSDT+0.11%JUPUSDT-3.39%INJUSDT-1.83%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-0.97%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.05%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.41%IOTAUSDT-3.42%AXSUSDT-2.25%FARTCOINUSDT-2.86%EOSUSDT-2.41%DYDXUSDT-1.72%ORDIUSDT-0.35%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.44%AAPL+3.15%GOOGL+0.44%MSFT-0.14%AMZN-0.22%TSM-1.32%SPCX+0.84%AVGO-0.58%META-1.20%TSLA-0.40%SKHY-4.06%MU-4.40%BRK-B-0.25%LLY-0.13%JPM-0.68%WMT-0.14%AMD-3.07%V-0.22%XOM+0.64%ASMLa-1.66%JNJ-0.16%INTC-4.61%MA-0.60%0700.HK-1.94%1398.HK+0.79%ORCL-3.99%ABBV+0.96%BAC-0.52%CSCO-1.09%CVX-0.39%COST-0.17%KO+0.61%LRCX-4.98%CAT-1.42%AP2d-1.55%0005.HK-0.78%AMAT-2.60%UNH-1.05%HSBA.L-1.30%DELL-3.48%PG+0.46%MS-1.08%GE-0.65%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.26%HD-1.88%0939.HK+1.66%GS-1.16%NZDJPY-2.62%AUDJPY-1.83%CHFJPY-1.60%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.25%USDJPY-1.23%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.97%USDNOK+0.91%USDSEK+0.88%AUDNZD+0.82%EURZAR+0.80%EURNOK+0.73%GBPZAR+0.72%EURSEK+0.71%AUDCAD-0.69%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.61%USDTHB+0.60%CHFNOK+0.57%GBPAUD+0.57%CHFSEK+0.55%AUDSGD-0.54%USDMXN+0.51%USDPLN+0.43%NZDSGD-0.42%CADCHF+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.27%EURPLN+0.26%SGDJPY+0.24%AUDCHF-0.23%NZDMXN-0.21%EURHKD-0.18%USDDKK+0.17%USDILS+0.16%USDTRY+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%AUDNOK+0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%EURCNH-0.05%EURCZK-0.05%USDCAD-0.05%USDCOP-0.04%EURGBP+0.04%GBPUSD-0.02%USDHKD+0.02%GBPSGD+0.02%EURUSD0.00%EURDKK0.00%XPTUSD-5.92%XAGUSD-5.06%GAGUSD-5.06%UKOIL+4.96%HG1-4.82%USOIL+4.74%XNGUSD+1.63%GAUUSD-1.55%XAUUSD-1.55%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.37%ETHUSD-0.03%USDTUSD-0.02%XRPUSD-2.84%SOLUSD-1.64%TRXUSDT+0.24%ZECUSDT-8.36%DOGEUSD-2.56%XMRUSDT+0.47%LINKUSD-1.12%XLMUSD-1.17%BCHUSDT-9.67%LTCUSD-1.50%UNIUSD-1.03%TONUSD+24.88%HBARUSDT-2.32%SUIUSD-3.99%TAOUSDT-5.17%AAVEUSD-2.21%DOTUSDT-1.56%ICPUSDT-0.72%ONDOUSDT-2.95%WLDUSDT-2.43%ATOMUSDT-2.11%ARBUSDT+0.11%JUPUSDT-3.39%INJUSDT-1.83%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-0.97%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.05%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.41%IOTAUSDT-3.42%AXSUSDT-2.25%FARTCOINUSDT-2.86%EOSUSDT-2.41%DYDXUSDT-1.72%ORDIUSDT-0.35%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
CV

CVRx, Inc. (CVRX)

NASDAQ • Healthcare

$2.83
-$0.1 (-3.4%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$2.9
Previous Close$2.83
Day Range$2.76 - $2.95
Avg. Volume (3M)875.6K
Market Cap$73.3M
52 Week Range
$2.2$11.3
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$15.7M100%
Gross Profitminus cost of goods$13.7M87%

In plain terms: out of every $100 in revenue, CVRx, Inc. currently loses $89.

Fundamentals & Financials

Revenue (TTM)
$61.1M
Net Income (TTM)
-$51.9M
EPS (TTM)
-$1.98
ROA (TTM)
-56.31%
Current Ratio
8.04

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-9.5%Q1 2026-$0.46
+2.0%Q2 2026-$0.5
-1.0%Q3 2026-$0.53
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About CVRx, Inc.

CVRx, Inc. develops neuromodulation therapy for cardiovascular disease and is listed on the NASDAQ as CVRX. The company operates in medical devices, centered on Barostim for heart failure with reduced ejection fraction, and generated $56.7 million of revenue in FY2025.

Name
CVRx, Inc.
CEO
Kevin Hykes
Website
www.barostim.com
Industry
Healthcare
Year Founded
2000
Employees
223

Today's Snapshot

AI-generated

CVRX is trading 3.5% lower at 2.73, while its sector was flat. Hagens Berman, an investor law firm, announced an investigation into CVRx over potential securities fraud.

Trading Volume

Below 10d avg (575.2K)

115.2K

vs S&P 500 Today

Underperforming Market

-2.97%

Updated: September 10, 2026 at 16:36 UTC

Technical Indicators

1 Buy2 Neutral5 Sell
CVRX shows a neutral technical mix with mild bearish pressure in price action offset by supportive intraday flow. ADX indicates little trend strength, while momentum indicators are skewed negative — RSI in the mid-30s and CCI below zero — and MACD is modestly negative. Price remains beneath short- and medium-term moving averages and well below longer-term averages, yet OBV and VWAP read as buyers, implying some accumulation intraday. Volatility is elevated by ATR. Technical takeaway: indicators overall produce a neutral bias with short-term downside pressure balanced by volume support.
All signals
  • EMA (5 indicators)$2.96 - $6.18
    Sell
  • RSI (14)36.26
    Neutral
  • Stochastic %K (14, 3, 3)16.21
    Buy
  • MACD Level (12, 26)-0.33
    Neutral

Peers & Related Assets

CERSCerus Corporation
$2.51-1.2%
MASS908 Devices Inc.
$9.69-1.2%
VMDViemed Healthcare, Inc.
$8.76-0.3%
QTRXQuanterix Corporation
$2.65-2.9%
NNOXNano-X Imaging Ltd.
$0.78-16.2%
SGHTSight Sciences, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.